Skip to main content

Calif. Judge Clears Drug Companies Off Opioid Liabilities

Calif. Judge Clears Drug Companies Off Opioid Liabilities

Calif. Judge Clears Drug Companies Off Opioid Liabilities

Introduction

A California jury has cleared four major drug companies from liabilities in the opioids epidemic litigation that demanded the companies to pay tens of billions of dollars to compensate for the opioid crisis.

Allergan, Endo, Johnson & Johnson (J&J) and Teva are the companies involved in the litigation. All the companies faced similar allegations that they used tricky marketing strategies to increase sales of opioids.

The companies attorney said that their clients are not responsible for fueling the opioid crisis. He added that if the company would have been found liable for the epidemic, it would have had to pay for costly public health and drug treatment programs that were acceptable on the drugmakers' part.

According to the findings provided by the court, the plaintiffs failed to prove an actionable public nuisance against the defendants, and the marketing and promotion of the drugs were appropriate which were not intended to harm the users.

The current ruling is a significant victory for the drugmakers considering the ever-increasing number of opioid lawsuits against them.

As per the data provided by the Centers for Disease Control and Prevention, the nationwide death rate due to opioid overdose is soaring, with nearly 100,000 deaths of Americans in 12 months.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!